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Average electron density (a.u.)

Aim: The similarity in the biological function of the bioisosteric pair, carboxyl and sulfonamide functional
groups, is studied using the quantitative tool, average electron density of the bioisosteric moiety in drug
molecules and the qualitative tool, electrostatic potential. Results/methodology: Five different capping
groups (methyl, phenyl, chlorine, hydrogen and amine) were considered to investigate the effect of the
environment on the properties of the bioisosteres. The molecules were considered in their neutral and
anionic forms to account for the change in pH depending on the medium of the drug–receptor interactions. Conclusion: The new developed approach, average electron density, is not only advantageous as
a qualitative descriptor, it is also more consistent compared with the conventionally accepted method,
electrostatic potential, especially for the anions.
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Bioisosterism is the replacement of functional groups in a drug molecule while keeping similar biological properties [1,2]. Bioisosteres are useful to enhance the physiochemical [3–9], pharmacological [10–16] and
pharmacodynamics/pharmacokinetic properties of drugs [17–26]. For example, tetrazole has been studied as a
bioisostere of carboxylic acid in the treatment of the neurodegenerative Alzheimer’s disease [3,5]. The substitution
with tetrazole, for example, in β-site amyloid precursor protein cleaving enzyme 1 inhibitors, is mandatory to avoid
the difficulty in crossing the blood–brain barrier which is highly hydrophobic [27,28]. Bioisosteres are classified
as classical if the functional groups are isoelectronic [29]; otherwise they are nonclassical with groups that could
possibly differ in the number of atoms, the 3D structure, the volumes and the number of valence electrons [30].
While the similarity is obvious for classical bioisosteres, it is not for the nonclassical ones. Often, bioisosterism is
explained by looking at similarities in the molecular electrostatic potentials (ESPs) [30–32]. Recently, there have been
two studies where two examples of nonclassical bioisosteres were explained using a new quantitative descriptor,
namely the average electron densities, defined as the ratio of the total electron population of the bioisosteric group
to its volume [32,33].
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Table 1. Comparison of some chemical and physical properties of 1,1,1-trichloro-N-methylmethanesulfonamide and
acetic acid.
Property

1,1,1-trichloro-N-methylmethanesulfonamide

Acetic acid

Number of atoms in the bioisostere

9

4

Molecular shape of the bioisostere

Open chain

V-shaped

Monoisotopic MW (g mol-1 )

210.90

60.02

Number of hydrogen bond acceptors

3

3

Number of hydrogen bond donors

1

1

LogP

1.3

-0.2

Polar surface are (˚A2 )

55

37

Data taken from [39,40].

In the first study, the authors looked at the carboxylate and tetrazole anion with three different environments,
that is, with methyl, hydrogen, and chlorine as capping groups. In all cases, the average electron densities of the
bioisosteres were identical up to three decimal places, 0.066 a.u. [32]. The second set of bioisosteres considered
was methylsquarate and acetic acid [33]. In this study, the authors looked at the neutral and the ionic forms
of the molecules, with four different capping groups, namely methyl, hydrogen, chlorine, and a phenyl ring.
The quantitative similarity in the average electron densities of the bioisosteric groups was obvious for all cases
considered. The authors have also concluded that the illustrative molecular ESPs failed at showing the similarities
in the dispositions of the positive and negative lobes for the bioisosteres in the anionic forms.
The partitioning of a molecule into atomic basins using the quantum theory of atoms in molecules (QTAIM) [34–
36] allows the evaluation of properties of atoms in molecules, and subsequently bioisosteres in drug molecules.
In QTAIM, the zero flux surfaces separate atoms into their own atomic basins. Then by operating different
mathematical operators on the atomic basins, followed by numerical integrations, atomic properties of atoms
in molecules can be evaluated. These properties include, volumes, charges, electron densities, areas, and average
electron densities.
In this study the bioisosterism of the sulfonamide and the carboxyl groups will be investigated using molecular
ESPs and average electron densities. A carboxyl group could be substituted by a sulfonamide bioisostere [37] in
angiotensin II receptor antagonists [38]. The efficacy of the drug as the carboxylic acid group is replaced with the
sulfonamide group increases by a factor of three. The IC50 (nM) drops from 275 with the carboxylic acid to 100
with the sulfonamide group. Squarate and tetrazole, which are other common bioisosteres of carboxyl, have IC50
(nM) of 25 and 3, respectively. According to the IC50 (nM), tetrazole has the highest efficacy, yet squarate is a
better bioisostere as it reduces the blood pressure in hypertensive cases.
Table 1 summarizes some of the differences in the chemical and physical properties of acetic acid and 1,1,1trichloro-N-methylmethanesulfonamide [39,40]. The pKa of acetic acid (4.76) is smaller than that of a sulfonamide
with -CF3 as an R group (6.3) [41]. Thus, 1,1,1-trichloro-N-methylmethanesulfonamide is more acidic than acetic
acid and gives its sulfonamide proton more readily. Both acids will, however, deprotonate at physiological pH of
7.4.
Methodology
Geometry optimization was completed in the gas phase using the Gaussian 09 package [42]. The density functional
theory (DFT) [43,44] B3LYP functional [45–47] was used with an augmented triple-ζ Pople basis set with diffuse
functions, a level of theory denoted by B3LYP/6–311++G(d,p)//B3LYP/6–311++G(d,p). The same level of
theory was used to generate electron densities and molecular ESPs. The molecules were confirmed to be minima
by checking for the absence of imaginary frequencies. The numerical integrations in G09 were evaluated using
ultrafine pruned (99,590) grids. The ‘tight’ self-consistent field (SCF) and optimization criteria were imposed while
disregarding symmetry in the molecule.
The atomic integrations were completed according to QTAIM using the AIMAll package [48]. The Lagrangian
values of all atoms varied from 10-7 to 10-3 a.u. The limits for the volumes of the atomic basins were defined by the
internal zero-flux interatomic surfaces within the molecular interior and up to the 0.001 a.u. isodensity envelope
for the external atoms.
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117.18°/2.52Å

129.45°/2.27Å

123.89°/2.56Å

119.73°/2.22Å

121.86°/2.26Å

Figure 1. Optimized geometries with the labeled atoms of the anionic (left) and neutral (right) forms of two
bioisosteres ( SO2 NCF3 -/ SO2 NHCF3 on the top and CO2 - / CO2 H at the bottom) capped with a phenyl ring.
Conformer 1 of the carboxylic bioisostere is displayed in the middle and conformer 2 is on the right. The numbers
below each molecule refer to angle/distance measurements, that is,  OSO/dOO (top) and  OCO/dOO (bottom).

The protonated bioisosteres, R SO2 NHCF3 and R CO2 H, and their corresponding anionic forms, R SO2 NCF3 and R CO2 - have been considered with five different capping groups, R = CH3 , H , Cl , C6 H5 , or NH2 . The
capping elements hydrogen and chlorine were chosen as two elements with significantly different electronegativities.
The methyl group is the simplest R group that can be used as a capping group; the phenyl ring and the amine group
were chosen because they are ubiquitous in drug molecules. In the case of the amine capping group, the hydrogen
on the middle nitrogen is more acidic than the hydrogen atoms on the terminal amine. Thus, upon deprotonation,
the NH2 SO2 NCF3 - is considered.
Results & discussion
Figure 1 displays the optimized geometries of the neutral and anionic forms of the bioisosteres capped with a phenyl
group. The OSO angle of the sulfonamide is wider in the neutral form (124◦ ) compared with the ionic form (117◦ )
and the OO distance is consequently longer in the neutral molecule by 0.04 Å. This observation is reversed in
the carboxyl group: the OCO angle is wider in the acetate (129◦ ) compared with both conformers of acetic acid
(120◦ and 122◦ ). The OO distances are consistently bigger (but not proportionally) for wider OCO angles. Two
conformers are considered because they are both equally populated according to Boltzmann distribution [33], yet
they might have significantly different biological interactions with the receptor. This is because of the orientation
of the hydrogen in the carboxylic group, which can either enter the active site or remain oriented away from it.
Average electron densities of the bioisosteric groups in the neutral molecules

The properties for the protonated sulfonamide and both conformers of carboxylic acid capped with five different
R groups are listed in Table 2. The atomic properties of all the atoms in all the molecules considered in this study
are listed in detail in the Supplementary Information. The sums of properties for the bioisosteric groups or the
capping groups (listed in Tables 2 & 3) are obtained by summing the corresponding properties of all the atoms
constituting each group.
Regardless of the capping group, the average electron densities of the two conformers of the carboxyl group are
identical to three decimal places; they vary only by a maximum of 0.0002 a.u., for example, from 0.0732 and
0.0734 for the carboxyl conformers 1 and 2 of benzoic acid, respectively (see Table 2). This slight variation is
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Table 2. Properties of the neutral sulfonamide bioisostere (left), carboxyl conformer 1 (middle) and carboxyl conformer 2
(right) capped with a phenyl ring, methyl group, chlorine, hydrogen, and an amine group (listed sequentially).
Neutral molecules

Cap group
Cap group
Cap group

N
(a.u.)

V
(a.u.)

<>
(a.u.)

q
(a.u.)

Group

N
(a.u.)

V
(a.u.)

<>
(a.u.)

q
(a.u.)

Group

N
(a.u.)

V
(a.u.)

<>
(a.u.)

q
(a.u.)

⌺ bioisostere
⌺ capping group

73.48
40.52

657.29
595.39

0.1118
0.0681

-0.48
0.48

⌺ bioisostere
⌺ capping group

23.16
40.84

316.46
728.96

0.0732
0.0560

-0.16
0.16

⌺ bioisostere
⌺ capping group

23.11
8.92

314.93
231.73

0.0734
0.0385

-0.11
0.08

⌺ bioisostere
⌺ capping group

73.47
8.53

773.94
205.85

0.0949
0.0414

-0.47
0.47

⌺ bioisostere
⌺ capping group

23.15
8.85

321.83
216.16

0.0719
0.0410

-0.15
0.15

⌺ bioisostere
⌺ capping group

23.11
8.89

320.88
217.47

0.0720
0.0409

-0.11
0.11

⌺ bioisostere
⌺ capping group

73.12
16.88

770.03
207.51

0.0950
0.0814

-0.12
0.12

⌺ bioisostere
⌺ capping group

22.80
17.20

309.94
221.47

0.0736
0.0777

0.20
-0.20

⌺ bioisostere
⌺ capping group

22.80
17.20

310.07
221.51

0.0735
0.0776

0.20
-0.20

⌺ bioisostere
⌺ capping group

73.42
0.58

794.98
28.72

0.0924
0.0200

-0.42
0.42

⌺ bioisostere
⌺ capping group

23.08
0.92

331.86
46.94

0.0695
0.0196

-0.08
0.08

⌺ bioisostere
⌺ capping group

23.05
0.95

331.12
49.17

0.0696
0.0194

-0.05
0.05

⌺ bioisostere
⌺ capping group

73.12
8.88

770.56
170.59

0.0949
0.0521

-0.12
0.12

⌺ bioisostere
⌺ capping group

22.71
9.29

313.44
176.84

0.0725
0.0525

0.29
-0.29

⌺ bioisostere
⌺ capping group

22.71
9.29

312.40
179.14

0.0727
0.0519

0.29
-0.29

73.32

753.36

0.0978

-0.32

22.98

318.71

0.0721

0.02

22.95

317.88

0.0722

0.05

0.19

54.68

0.0079

0.19

0.21

8.55

0.0016

0.21

0.19

8.42

0.0016

0.19

179.80

0.0457

-0.05

75.70

0.0214

0.18

Bioisostere

Group

Bioisostere

Bioisostere

Bioisostere
Bioisostere
Average
bioisostere
SD
bioisostere
Average
capping group
SD
capping group

15.08

241.61

0.0526

0.32

15.35

210.93

0.0237

0.19

Average
bioisostere
SD
bioisostere
Average
capping group
SD
capping group

15.42

278.07

0.0494

-0.02

15.33

261.73

0.0213

0.21

Average
bioisostere
SD
bioisostere

Average
capping group 9.05
SD
capping group 5.75

The properties include electron population, volume up to the 0.001 a.u. isodensity envelope, average electron density, and electric charge, all in atomic units. The average properties and
the SDs are also included.
a.u.: Atomic units; ⬍ ⬎: Average electron density; N: Electron population; SD: Standard deviation; q: Electric charge; V: Isodensity envelope.
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Table 3. Properties of the sulfonamide anion (left) and the carboxylate (right) capped with a phenyl ring, methyl group,
chlorine, hydrogen, and an amine group (listed sequentially).
Anionic molecules

Cap group

Cap group

N (a.u.)

V (a.u.)

<> (a.u.)

q (a.u.)

Group

N (a.u.)

V (a.u.)

<> (a.u.)

q (a.u.)

⌺ bioisostere
⌺ capping group

73.25
40.75

665.88
609.77

0.1100
0.0668

-1.25
0.25

⌺ bioisostere
⌺ capping group

22.81
41.19

272.17
618.68

0.0838
0.0666

-0.81
-0.19

⌺ bioisostere
⌺ capping group

73.29
8.71

675.35
174.12

0.1085
0.0500

-1.29
0.29

⌺ bioisostere
⌺ capping group

22.87
9.13

280.17
186.28

0.0816
0.0490

-0.87
-0.13

⌺ bioisostere
⌺ capping group

72.89
17.11

669.94
177.15

0.1088
0.0966

-0.89
-0.11

⌺ bioisostere
⌺ capping group

22.10
17.90

256.81
243.25

0.0861
0.0736

-0.10
-0.90

⌺ bioisostere
⌺ capping group

73.32
0.68

691.42
26.59

0.1060
0.0256

-1.32
0.32

⌺ bioisostere
⌺ capping group

22.89
1.11

288.05
46.12

0.0795
0.0241

-0.89
-0.11

⌺ bioisostere
⌺ capping group

72.94
9.05

793.59
185.90

0.0919
0.0487

-0.94
-0.05

⌺ bioisostere
⌺ capping group

22.59
9.41

339.58
198.13

0.0665
0.0475

-0.59
-0.41

73.14

699.24

0.1051

-1.14

22.65

287.36

0.0795

-0.65

0.20

53.63

0.0075

0.20

0.33

31.40

0.0077

0.33

15.75

258.49

0.0521

-0.35

15.41

214.44

0.0193

0.33

Bioisostere

Group

Bioisostere

Bioisostere

Bioisostere
Bioisostere
Average
bioisostere
SD
bioisostere
Average
capping
group
SD
capping
group

15.26

234.71

0.0575

0.14

15.39

219.86

0.0263

0.21

Average
bioisostere
SD
bioisostere
Average
capping
group
SD
capping
group

The properties include electron population, volume up to the 0.001 a.u. isodensity envelope, average electron density, and electric charge, all in atomic units. The average properties and
the SD are also included.
a.u.: Atomic units; ⬍ ⬎: Average electron density; N: Electron population; SD: Standard deviation; q: Electric charge; V: Isodensity envelope.
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25

335
N

V
330

20
325

N (a.u.)

315
10

V (a.u.)

320

15

310
305

5
300
0

295
Phenyl

Methyl

Chlorine Hydrogen Amine

Conformer 1

Phenyl

Methyl

Chlorine Hydrogen Amine

Conformer 2

Figure 2. Electron populations and volumes of the carboxyl bioisostere in both conformers capped with five
different capping groups.
a.u.: Atomic units; N: Electron population; V: Volume.

mainly a result of a change in the volume and not a change in the electron population (see Figure 2), as the latter
is minimal to the point that electron populations are actually identical for both conformers in the cases of the
chlorine (22.80 e- ), and the amine (22.71 e- ) capping groups. This suggests that QTAIM captures the similarity of
an identical carboxyl groups by the similarity in electron populations, yet it differentiates their 3D arrangements
(conformational changes) by the slight variations in their volumes, for example, 313.44 bohr3 and 312.40 bohr3 for
the carboxyl groups when capped with amine. The change in the average electron densities as a result of changing
the capping group is more pronounced (compared with changing conformations), where these values range from a
minimum of 0.0695 a.u. (H-COOH, conformer 1) to a maximum of 0.0736 a.u. (Cl-COOH, conformer 1).
Considering only the methyl, chlorine, and amine capping groups, the average electron density (AED) of the
sulfonamide bioisostere is 0.0949 ± 3.2 × 10-5 a.u. (with a volume of 771.51 ± 2.12 bohr3 ). This AED decreases
slightly to 0.0924 a.u. with the hydrogen capping atom (as the volume of the bioisostere expands slightly to
794.98 bohr3 ) and it increases significantly to 0.1118 a.u. with the phenyl capping group (as the volume of the
bioisosteres shrinks by ∼14.8% to 657.29 bohr3 ). Again, the electron population of the sulfonamide remains
almost constant, in all cases, at an average of 73.32 ± 0.19 e- .
As depicted in Figure 3, the charge of the carboxyl bioisostere alternates between positive and negative depending
on the capping group (e.g., +0.20 with chlorine vs -0.15 e- with methyl), and in some cases its value varies slightly
depending on the conformational change (e.g., -0.16 e- vs -0.11 e- in conformers 1 and 2 of benzoic acid). The
charge of the sulfonamide group is always negative, but varies in magnitude from -0.12 e- when capped with
chlorine or amine to -0.46 ± 0.03 e- when capped with phenyl, methyl, and hydrogen.
Overall, the sulfonamides have an average electron population of 73.32 ± 0.19 e- , an average volume of
753.36 ± 54.68 bohr3 and an average AED of 0.0978 ± 0.0079 a.u.; while the corresponding values for the carboxyl
group (averaged over both conformers) are 22.79 ± 0.19 e- , 318.29 ± 8.01 bohr3 and 0.0722 ± 0.0015 a.u.,
respectively. Excluding the outlier of sulfonamide capped with a phenyl group, on average, the AED of the carboxyl
group (0.0722 ± 0.0015 a.u.) are smaller by 23.4% compared with the AED of the sulfonamide bioisostere
(0.0943 ± 0.0013 a.u.).
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0.30
Sulfonamide
Carboxyl, conformer 1
Carboxyl, conformer 2

0.20

0.10

q (a.u.)

0.00
Phenyl

Methyl

Chlorine

Hydrogen

Amine

-0.10

-0.20

-0.30

-0.40

-0.50

Figure 3. Charge of the carboxyl (both conformers) and sulfonamide bioisosteres capped with five different
capping groups.
a.u.: Atomic units; q: Charge.

Carboxylate
Sulfonamide anion

Cl

Capping group

NH2

C5H5

CH3

H

0.00

-0.20

-0.40

-0.60

-0.80

-1.00

-1.20

-1.40

Charge of the bioisostere (a.u.)

Figure 4. Charge of the carboxylate and sulfonamide anion bioisosteres capped with five different capping groups.
a.u.: Atomic units.

Average electron densities of the bioisosteric groups in the anionic molecules

The charges in Table 3 and Figure 4 show that the carboxylate group does not carry a full negative charge, it is
partially negatively charged, and the rest of the charge is distributed on the capping group. The sum of both partial
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Average electron density (a.u.)

0.12
0.10
0.08
0.06
0.04
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0.00
-C5H5

-CH3
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-NH2
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-CH3

-Cl
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-NH2

Bioisostere
Sulfonamide

Carboxyl, conformer 1

Carboxyl, conformer 2

Sulfonamide anion

Carboxylate

Figure 5. Average electron densities of the bioisosteres with five different capping groups (left set) and the average electron density
of the five capping groups (right set).
a.u.: Atomic units.

charges, for the bioisostere and the capping group, always adds to unity, as it should. Depending on the capping
group, the partial charge of the carboxylate group is in the following order (where the capping group is indicated in
parentheses): -0.89 e- (H) > -8.7 e- (methyl) > -8.1 e- (phenyl) > -0.59 e- (amine) > -0.1 e- (Cl). The sulfonamide
anion group withdraws more charge than the carboxylate; in some cases its charge exceeds unity leaving a partial
positive charge on the capping group in such a way the sum of the charges for the entire molecule adds to -1. The
ranking of the charges, depending on the capping group is as follows: -1.32 e- (H), -1.29 e- (methyl), -1.25 e(phenyl), -0.94 e- (amine) and -0.89 e- (Cl). Even though the sulfonamide anion carries more negative charge than
the carboxylate, they both follow the same ranking trend with the five capping groups as shown in Figure 4.
The average AED for sulfonamide anion capped with five different groups is 0.1051 ± 0.0075 a.u., with the
range being from 0.0919 to 0.1100 a.u. (see Table 3). The small standard deviation in the AED indicates that,
irrespective of the capping group, the AED property is transferable. In other words, regardless of which drug it is
used with, a given bioisostere would have a similar AED. A similar observation is made for the carboxylate, where
the AED values range from 0.0795 to 0.0861 a.u., with the amine-capped bioisostere being an outlier with an AED
of 0.0665 a.u. For the carboxylate anion, the average AED is 0.0795 ± 0.0077 a.u. (or 0.0827 ± 0.0028 a.u. if the
amine capping group is excluded, i.e., 21.3% smaller than the average AED for the sulfonamide anion case). Again,
the variation is more because of the volumes than it is of the electron populations which span a very narrow range
of 22.10–22.89 a.u. for the carboxylate and 72.89–73.32 a.u. for the sulfonamide anion. Overall, it is important
to note that the AED of the carboxylate is smaller than that of the sulfonamide anion by 24.4%. This difference
cannot be judged as small or large as there are no references to compare with. However, it is worth noting that
the similarity in the bioisosteres is remarkable as it is captured up to 75.6% despite all the changes in the number
and identities of the atoms (eight atoms in the sulfonamide including one S and three Cl vs three atoms in the
carboxylate), the structure of the bioisosteres and many other properties listed in Table 1. More prominently, it is
worth appreciating this 75.6% similarity in AED given (as will be shown below) the substantial difference observed
in the classic way of assessing bioisosteres using ESP.
AED of the bioisosteric groups in the neutral compared with the anionic molecules

The average AED in the carboxyl group (0.0722 a.u., average over both conformers) versus the carboxylate group
(0.0795 a.u.) are off by only 9.2% (see Figure 5) which is a very small deviation to be compared with a much
more pronounced difference in the ESP (as will be explained in the last section). Those of the sulfonamide
(0.0978 a.u.) and sulfonamide anion (0.1051 a.u.) are off by a small percent of 6.9% (see Figure 5). The ratio
of AEDsulfonamide /AEDcarboxyl = 1.35 and AEDsulfonamide anion /AEDcarboxylate = 1.32, which are similar up to 97.8%.
These small variations in the AED between the neutral and anionic bioisosteres suggest that, regardless of the pH
of the biological medium (i.e., irrespective of the protonation state), the AED can still be used as a tool to identify
and describe bioisosteres.
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The most important comparison in this study is between the AED values of the carboxyl and the sulfonamide
bioisosteres; they are off by 26.2%. Those of the anion counterparts are off by 24.4% (see Figure 5). These
differences are not necessarily minimal. Nonetheless, the AED descriptor is not only valuable for a quantitative
assessment (that cannot otherwise be obtained with traditional evaluators, i.e., ESPs), it is also more reliable than
ESP in identifying similarities between anionic bioisosteres (as will be described below in the last section). It is
worth mentioning that the 75.6% similarity between the bioisosteric groups, while not maximal, is not coincidental
because, even for identical capping groups, the AED is not the same. For example, the AED of the chlorine with
the sulfonamide anion bioisostere is 0.0966 a.u., while it is 0.0736 a.u. with the carboxylate, that is, a difference of
23.8% for one single identical atom (not even a group of atoms). This conclusion is supported by the findings of
the previous study in reference [32].
Figure 5 clearly shows (in the left set) that the bioisosteres have similar AED values irrespective of their identity,
charge, conformer, or capping group. The AED values of the sulfonamide and sulfonamide anions are consistently
higher than those of the carboxyl and carboxylate bioisosteres. However, they remain comparable within 75.6%
as discussed above. This similarity is not intuitive given the difference in the atomic and structural composition
of the carboxyl and sulfonamide bioisosteres. This similarity is not coincidental either, as can be obvious from the
right side where the AED of the five chosen capping groups (with different atomic and structural composition)
vary a lot more drastically compared with the variations in the AED of the bioisosteres, for example, the AED of
the hydrogen with sulfonamide is 70.5% smaller than that of the phenyl ring with sulfonamide. This similarity in
the AED of the carboxyl and sulfonamide bioisosteres is deemed to be valuable in explaining bioisosterism because,
as will be shown in the last section, the similarity between bioisosteres is not necessarily clear from the qualitative
molecular ESPs, which are commonly used to explain the resemblance in the biological activity of these different
bioisosteres.
Molecular ESP of the neutral & anionic molecules

Molecular ESPs were first introduced in the 1970 [49], and they are ubiquitously used for the identification of
electrophilic and nucleophilic sites for predicting reactivities and gaining more insight about the directions of
interactions, and thus mechanisms of various processes [50–54]. The molecular ESP, V(r), is given by:
V(r )  
A

Z(A)
(r )

dr 
R (A)  r
r  r

where Z(A) is the atomic number, R(A) is the position vector of nucleus A, r is the position vector of the point at
which V(r) is evaluated and ρ(r’) is the electron density at a position vector r’.
The ESPs in Figure 6 clearly depict the similarity in the disposition of the red lobes, for any given bioisostere,
with the five different capping groups. The red lobes of the sulfonamide bioisostere are almost symmetric in size
and shape. The ESP of both conformers of the carboxyl group have two lobes with one being a lot bigger in size
and different in shape than the other. However, the disposition of these lobes varies slightly from being adjacent, in
conformer 1, with a separating distance of roughly 3.3 Å; to being across two sides of the molecule, in conformer 2,
with a separating distance of roughly 5.1 Å (i.e., ∼1.5-times the separation in conformer 1). While the ESP varies
more with different conformers compared with different capping groups, the AED showed the opposite trend (as
discussed above).
The ESP of the sulfonamide is closer to that of the carboxyl group in conformer 1 than conformer 2. The
distance, on average across all capping groups, between the lobes in conformer 1 (3.31 Å) is 18.9% smaller than
that between the lobes of the sulfonamides (4.08 Å). It is, however, 25% larger in conformer 2 (5.09 Å) compared
with the sulfonamides. This percent difference matches with the 26.2% difference in the AED of the carboxyl and
the sulfonamide bioisosteres.
It is noticeable, by glancing at the ESP of the anionic molecules shown in Figure 7, that there are no clear
similarities in the disposition of the red lobes between the bioisosteres. The sulfonamide anions have three lobes
as opposed to only two lobes for the carboxylates (the carboxylate capped with a chlorine is an exception where
the C-Cl bond, 2.9 Å, is much more stretched than the average C-Cl bond, 1.7 Å, suggesting that the Cl-COOoptimized to a CO2 molecule and a chloride anion where the big red lobe of the ESP is accumulated). It could be
argued that only two of the lobes of the sulfonamide enter the active site of the receptor, but it would not be clear,
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Figure 6. Electrostatic potential surfaces of the neutral bioisostere - SO2 NHCF3 (top), - CO2 H, conformer 1 (middle)
and - CO2 H, conformer 2 (bottom) with the hydrogen, chlorine, amine, methyl and phenyl capping groups (from left
to right). Red is for negative and yellow is for positive values of the electrostatic potential. The numbers displayed in
˚A represent the distance between the centers of the negative lobes in red. The isodensity value is reported, in atomic
unit, for each molecule.

0.210 a.u./4.21 Å

0.190 a.u./4.23 Å

0.210 a.u./4.09 Å

0.208 a.u./4.19 Å

0.281 a.u./2.22 Å

0.247 a.u./NA

0.278 a.u./2.33 Å

0.280 a.u./2.27 Å 0.260 a.u./2.27 Å

0.193 a.u./4.01 Å

Figure 7. Electrostatic potential surfaces of the anionic bioisostere SO2 NCF3 - (top) and CO2 - (bottom) with the
hydrogen, chlorine, amine, methyl and phenyl capping groups (from left to right). Red is for negative and yellow is
for positive values of the electrostatic potential. The numbers displayed in ˚A represent the distance between the
centers of the negative lobes in red. The isodensity value is reported, in atomic unit, for each molecule.

based on the ESP, which two lobes will enter the active site. Even if the two upper lobes are assumed to enter the
active site, the average distance between these lobes is 4.1 Å; which is 1.8-times wider than that of the carboxylates
(2.3 Å), that is, a difference of 43.9% in the distance between the lobes of the two bioisosteres. Thus, by simply
looking at the ESP, it is difficult to strictly confirm a ‘lock-and-key’ complementarity between the bioisosteres at a
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given receptor. This is to be compared with the 24.4% difference in the AED of the carboxylates and sulfonamides.
Therefore, for assessing bioisosteric similarities, the AED descriptor is likely more accurate and more consistent
than the ESP tool. Another advantage of the AED is that it can quantify both the similarity in the bioisosteres and
the difference in the capping groups (as shown in Figure 5), which is not otherwise possible with the ESP.
Comparison of the ESP of the bioisosteric groups in the neutral & the anionic molecules
The neutral carboxyl groups (both conformers) and the anionic carboxylate group share the same number of red
lobes (see Figures 6 & 7), and a similar 3D topology, but only to a certain extent. The lobes of the neutral carboxyl
group have different sizes and shapes while they are perfectly symmetric in carboxylate. The distance between the
lobes vary from 3.3 Å and 5.1 Å in conformers 1 and 2 (respectively) to 2.3 Å in carboxylate. While the similarity
between the neutral and the anionic forms is not noticeably obvious with ESP, the AED of both forms were off by
only 9.2% (as described above). The similarity between the ESP of sulfonamide and sulfonamide anion is even less
pronounced (see Figures 6 & 7 for comparison). The neutral molecules have two lobes as opposed to three lobes
in the anionic form. It is worth noting, however, that the distance between the two upper lobes in the sulfonamide
anion is identical (4.1 Å, on average) to that of the neutral sulfonamide group. The AED values of the neutral and
anionic sulfonamides are off by only 6.9%.
Conclusion
In this study, the bioisosterism between carboxyl and sulfonamide groups is explored quantitatively using the
new descriptor, average electron densities and qualitatively using molecular ESPs. The bioisosteres were capped
with five different groups, namely a phenyl ring, methyl and amine groups, and chlorine and hydrogen atoms to
understand the effect of the environment on the properties of the bioisosteres. The molecules were considered in
their protonated and deprotonated forms as their status depends on the pH of the biological medium they are in.
The results suggest that AED is a more consistent quantitative descriptor for bioisosteres compared with the
illustrative qualitative ESP descriptor. The topology of the ESP of the neutral molecules shows similarity in having
two lobes of negative values at slightly different positions. The separation of these lobes is off by 25% for the
sulfonamide compared with the carboxyl group, which is aligned with the 26.2% difference of the AED of these
bioisosteres. However, the ESP of the sulfonamide anion and the carboxylate bioisosteres had different topologies,
where the former had three lobes of negative values and the latter had only two. While the ESP of the anionic
forms did not clearly show a similarity for the bioisosteres, the AED of these groups exhibit 75.65% similarity.
It was shown that the capping groups marginally affect the values of the AED: they are 0.0978 ± 0.0079 a.u.
for the sulfonamide and 0.0722 ± 0.0015 a.u. for the carboxyl group, both capped with the five groups. The
corresponding values for sulfonamide anion and carboxylate are 0.1051 ± 0.0075 a.u. and 0.0795 ± 0.0077 a.u.,
respectively. It was also shown that the ESP of the bioisosteres remains the same irrespective of the capping group
(in both the neutral and anionic forms).
Future perspective
This study will be extended by studying more bioisosteres in order to validate the usefulness of the AED as a standard
and accurate tool for evaluating bioisosteres. We hope that this will then permit us to predict new bioisosteres that
are hitherto unknown in the literature. The discovery of new bioisosteres would be an important advance in the
field of drug discovery and design.
Supplementary data
To view the supplementary data that accompany this paper please visit the journal website at: www.future-science.com/doi/suppl
/10.4155/fmc-2017-0136.
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Summary points
• Average electron density (AED) is a more consistent quantitative descriptor for bioisosteres compared with the
illustrative qualitative electrostatic potential (ESP) descriptor.
• The average AED of the neutral bioisosteres, sulfonamide and carboxyl, capped with five different groups (-C5 H5 ,
-CH3 , -Cl, -H and -NH2 ) are 0.0978 ± 0.0079 a.u. and 0.0722 ± 0.0015 a.u., respectively.
• The average AED of the two anionic bioisosteres, sulfonamide anion and carboxylate, with the same five capping
groups are 0.1051 ± 0.0075 a.u. and 0.0795 ± 0.0077 a.u., respectively.
• A given bioisostere would have a similar AED regardless of the capping group used or, in broader terms,
regardless of the drug it is part of.
• The ESP of the neutral forms of the bioisosteres reveals similarity by having two and only two negative lobes. The
ESP of conformer 1 of carboxyl is closer than that of conformer 2 to the ESP of sulfonamide.
• The ESP of the deprotonated bioisosteres did not reveal a clear similarity in the topology of the lobes, which
makes it difficult to determine, for drug design, the bioisosterism between sulfonamide anion and carboxylate
using ESP as a sole indicator.
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